AG
BCDA icon

Advisor Group’s BioCardia BCDA Stock Holding History

Advisor Group’s Portfolio BCDA Stock Details BCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2K Sell
37
-23
-38% -$1.35K ﹤0.01% 4950
2019
Q3 		$3K Buy
+60
New +$4.31K ﹤0.01% 4815

Other funds holding BCDA

LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Advisor Group's BCDA Position: Q4 2019 in Review

Advisor Group reduced its BioCardia (BCDA) stake by 38% in Q4 2019, selling an estimated $1.35K and leaving 37 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #4950.

Advisor Group first reported a position in BCDA in Q3 2019 and has held it in 2 quarters since. The position peaked at $3K in Q3 2019. 8 funds tracked by Wall St. Rank hold BCDA as of Q4 2019.

  • Advisor Group held 37 shares of BioCardia worth $2K as of Q4 2019.
  • Advisor Group sold 23 BioCardia shares in Q4 2019, an estimated $1.35K.
  • BioCardia made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4950 holding.
  • Advisor Group first reported a position in BioCardia in Q3 2019 and has held it in 2 quarters since.
  • Advisor Group's BioCardia position peaked at $3K in Q3 2019.
  • 8 funds tracked by Wall St. Rank held BioCardia as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.